Nanomedicines In Oral Cancer: Inspiration Comes from Extracellular Vesicles and Biomimetic Nanoparticles

References

• Burtness B , HaddadR, DinisJet al. Afatinib vs placebo as adjuvant therapy after chemoradiotherapy in squamous cell carcinoma of the head and neck: a randomized clinical trial. JAMA Oncol.5(8), 1170–1180 (2019).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD, JemalA. Cancer statistics, 2020. CA Cancer J. Clin.70(1), 7–30 (2020).
   PubMed Web of Science ®Google Scholar
• Morris LGT , ChandramohanR, WestLet al. The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform. JAMA Oncol.3(2), 244–255 (2017).
   PubMed Web of Science ®Google Scholar
• Papillon-Cavanagh S , LuC, GaydenTet al. Impaired H3k36 methylation defines a subset of head and neck squamous cell carcinomas. Nat. Genet.49(2), 180–185 (2017).
   PubMed Web of Science ®Google Scholar
• Chi AC , DayTA, NevilleBW. Oral cavity and oropharyngeal squamous cell carcinoma – an update. CA Cancer J. Clin.65(5), 401–421 (2015).
   PubMed Web of Science ®Google Scholar
• Chow LQM . Head and neck cancer. N. Engl. J. Med.382(1), 60–72 (2020).
   PubMed Web of Science ®Google Scholar
• Castellsagué X , AlemanyL, QuerMet al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J. Natl Cancer Inst.108(6), djv403 (2016).
   PubMedGoogle Scholar
• Marcazzan S , VaroniEM, BlancoE, LodiG, FerrariM. Nanomedicine, an emerging therapeutic strategy for oral cancer therapy. Oral Oncol.76, 1–7 (2018).
   PubMed Web of Science ®Google Scholar
• Bau DT , LippmanSM, XuEet al. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer119(24), 4277–4283 (2013).
   PubMed Web of Science ®Google Scholar
• Raza F , ZafarH, YouXet al. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers. J. Mater. Chem. B7(48), 7639–7655 (2019).
   PubMed Web of Science ®Google Scholar
• Johnson DE , BurtnessB, LeemansCRet al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers6(1), 92 (2020).
   PubMed Web of Science ®Google Scholar
• Vermorken JB , TrigoJ, HittRet al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J. Clin. Oncol.25(16), 2171–2177 (2007).
   PubMed Web of Science ®Google Scholar
• Cohen RB . Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC). Cancer Treat. Rev.40(4), 567–577 (2014).
   PubMed Web of Science ®Google Scholar
• Shi J , KantoffPW, WoosterR, FarokhzadOC. Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer17(1), 20–37 (2017).
   PubMed Web of Science ®Google Scholar
• Jain V , KumarH, AnodHVet al. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. J. Control. Rel.326, 628–647 (2020).
   PubMed Web of Science ®Google Scholar
• Chen XJ , ZhangXQ, LiuQ, ZhangJ, ZhouG. Nanotechnology: a promising method for oral cancer detection and diagnosis. J. Nanobiotechnol.16(1), 52 (2018).
   PubMedGoogle Scholar
• Shi X , ZhangCY, GaoJ, WangZ. Recent advances in photodynamic therapy for cancer and infectious diseases. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.11(5), e1560 (2019).
   PubMed Web of Science ®Google Scholar
• Neville BW , DayTA. Oral cancer and precancerous lesions. CA Cancer J. Clin.52(4), 195–215 (2002).
   PubMed Web of Science ®Google Scholar
• Rosenblum D , JoshiN, TaoW, KarpJM, PeerD. Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun.9(1), 1410 (2018).
   PubMed Web of Science ®Google Scholar
• Birrer MJ , MooreKN, BetellaI, BatesRC. Antibody-drug conjugate-based therapeutics: state of the science. J. Natl Cancer Inst.111(6), 538–549 (2019).
   PubMedGoogle Scholar
• Liu J , HuangY, KumarAet al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol. Adv.32(4), 693–710 (2014).
   PubMed Web of Science ®Google Scholar
• Zeng Y , MaJ, ZhanYet al. Hypoxia-activated prodrugs and redox-responsive nanocarriers. Int. J. Nanomed.13, 6551–6574 (2018).
   PubMed Web of Science ®Google Scholar
• Raza F , ZafarH, KhanMWet al. Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy. Mater. Adv.3(5), 2268–2290 (2022).
   Google Scholar
• Bie N , YongT, WeiZ, GanL, YangX. Extracellular vesicles for improved tumour accumulation and penetration. Adv. Drug. Deliv. Rev.188, 114450 (2022).
   PubMed Web of Science ®Google Scholar
• Kim OY , LeeJ, GhoYS. Extracellular vesicle mimetics: novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines. Semin. Cell Dev. Biol.67, 74–82 (2017).
   PubMed Web of Science ®Google Scholar
• Hussain Z , RahimMA, JanNet al. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: improved pharmacokinetics, cell internalization and anticancer efficacy. J. Control. Rel.335, 130–157 (2021).
   PubMed Web of Science ®Google Scholar
• Cao H , DanZ, HeXet al. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano.10(8), 7738–7748 (2016).
   PubMed Web of Science ®Google Scholar
• Cheng Y , ChenQ, GuoZet al. An intelligent biomimetic nanoplatform for holistic treatment of metastatic triple-negative breast cancer via photothermal ablation and immune remodeling. ACS Nano14(11), 15161–15181 (2020).
   PubMed Web of Science ®Google Scholar
• Ma W , ZhuD, LiJet al. Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. Theranostics10(3), 1281–1295 (2020).
   PubMed Web of Science ®Google Scholar
• Eguchi T , TahaEA, CalderwoodSK, OnoK. A novel model of cancer drug resistance: oncosomal release of cytotoxic and antibody-based drugs. Biology (Basel)9(3), 47 (2020).
   PubMedGoogle Scholar
• Song W , MusettiSN, HuangL. Nanomaterials for cancer immunotherapy. Biomaterials148, 16–30 (2017).
   PubMed Web of Science ®Google Scholar
• Ono K , EguchiT, SogawaCet al. HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. J. Cell. Biochem.119(9), 7350–7362 (2018).
   PubMed Web of Science ®Google Scholar
• Kosaka N . Decoding the secret of cancer by means of extracellular vesicles. J. Clin. Med.5(2), 22 (2016).
   PubMed Web of Science ®Google Scholar
• Lombardi M , ParolisiR, ScaroniFet al. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure. Acta Neuropathol.138(6), 987–1012 (2019).
   PubMed Web of Science ®Google Scholar
• Wang L , YinP, WangJet al. Delivery of mesenchymal stem cells-derived extracellular vesicles with enriched miR-185 inhibits progression of OPMD. Artif. Cells Nanomed. Biotechnol.47(1), 2481–2491 (2019).
   PubMed Web of Science ®Google Scholar
• Qiu Y , SunJ, QiuJet al. Antitumor activity of cabazitaxel and MSC-TRAIL derived extracellular vesicles in drug-resistant oral squamous cell carcinoma. Cancer Manag. Res.12, 10809–10820 (2020).
   PubMed Web of Science ®Google Scholar
• Li L , LuS, LiangXet al. γδTDEs: an efficient delivery system for miR-138 with anti-tumoral and immunostimulatory roles on oral squamous cell carcinoma. Mol. Ther. Nucleic Acids14, 101–113 (2019).
   PubMedGoogle Scholar
• Zhu G , CaoB, LiangXet al. Small extracellular vesicles containing miR-192/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma. Cancer Lett.506, 11–22 (2021).
   PubMed Web of Science ®Google Scholar
• Yang Z , LiuD, ZhouHet al. A new nanomaterial based on extracellular vesicles containing chrysin-induced cell apoptosis through let-7a in tongue squamous cell carcinoma. Front. Bioeng. Biotechnol.9, 766380 (2021).
   PubMed Web of Science ®Google Scholar
• Li S , YiM, DongBet al. The roles of exosomes in cancer drug resistance and its therapeutic application. Clin. Transl. Med.10(8), e257 (2020).
   PubMed Web of Science ®Google Scholar
• Peng Q , YangJY, ZhouG. Emerging functions and clinical applications of exosomes in human oral diseases. Cell Biosci.10, 68 (2020).
   PubMed Web of Science ®Google Scholar
• Jin J , LiX, HuBet al. Foxo1 deficiency impairs proteostasis in aged T cells. Sci. Adv.6(17), eaba1808 (2020).
   PubMed Web of Science ®Google Scholar
• Tai YL , ChenKC, HsiehJT, ShenTL. Exosomes in cancer development and clinical applications. Cancer Sci.109(8), 2364–2374 (2018).
   PubMed Web of Science ®Google Scholar
• Yin Z , YuM, MaTet al. Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. J. Immunother. Cancer9(1), e001698 (2021).
   PubMed Web of Science ®Google Scholar
• Chen G , HuangAC, ZhangWet al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature560(7718), 382–386 (2018).
   PubMed Web of Science ®Google Scholar
• Wu M , ChenZ, XieQet al. One-step quantification of salivary exosomes based on combined aptamer recognition and quantum dot signal amplification. Biosens. Bioelectron.171, 112733 (2021).
   PubMed Web of Science ®Google Scholar
• Sharma S , MasudMK, KanetiYVet al. Extracellular vesicle nanoarchitectonics for novel drug delivery applications. Small17(42), e2102220 (2021).
   PubMed Web of Science ®Google Scholar
• Li YY , TaoYW, GaoSet al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine36, 209–220 (2018).
   PubMed Web of Science ®Google Scholar
• Ludwig N , YerneniSS, RazzoBM, WhitesideTL. Exosomes from HNSCC promote angiogenesis through reprogramming of endothelial cells. Mol. Cancer Res.16(11), 1798–1808 (2018).
   PubMed Web of Science ®Google Scholar
• Qin X , GuoH, WangXet al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol.20(1), 12 (2019).
   PubMed Web of Science ®Google Scholar
• Xie C , DuLY, GuoF, LiX, ChengB. Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration. Mol. Cell. Biochem.458(1-2), 11–26 (2019).
   PubMed Web of Science ®Google Scholar
• Sun LP , XuK, CuiJet al. Cancer-associated fibroblast-derived exosomal miR-382-5p promotes the migration and invasion of oral squamous cell carcinoma. Oncol. Rep.42(4), 1319–1328 (2019).
   PubMed Web of Science ®Google Scholar
• Chen JH , WuATH, BamoduOAet al. Ovatodiolide suppresses oral cancer malignancy by down-regulating exosomal miR-21/STAT3/β-catenin cargo and preventing oncogenic transformation of normal gingival fibroblasts. Cancers (Basel)12(1), 56 (2019).
   PubMed Web of Science ®Google Scholar
• Li L , LiC, WangSet al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res.76(7), 1770–1780 (2016).
   PubMed Web of Science ®Google Scholar
• Sakha S , MuramatsuT, UedaK, InazawaJ. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci. Rep.6, 38750 (2016).
   PubMed Web of Science ®Google Scholar
• Wang Y , QinX, ZhuXet al. Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway. Oral Oncol.76, 34–41 (2018).
   PubMed Web of Science ®Google Scholar
• Wang X , QinX, YanMet al. Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression. J. Exp. Clin. Cancer Res.38(1), 151 (2019).
   PubMedGoogle Scholar
• Cai J , QiaoB, GaoN, LinN, HeW. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p. Am. J. Physiol. Cell Physiol.316(5), c731–c740 (2019).
   PubMed Web of Science ®Google Scholar
• Wang L , SongY, WangHet al. miR-210-3p-Ephrina3-PI3K/Akt axis regulates the progression of oral cancer. J. Cell Mol. Med.24(7), 4011–4022 (2020).
   PubMed Web of Science ®Google Scholar
• Higaki M , ShintaniT, HamadaA, RosliSNZ, OkamotoT. Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1). In Vitro Cell. Dev. Biol. Anim.56(3), 222–233 (2020).
   PubMed Web of Science ®Google Scholar
• Luo Y , LiuF, GuoJ, GuiR. Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC. Sci. Rep.10(1), 13739 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang Y , TangK, ChenL, DuM, QuZ. Exosomal circGDI2 suppresses oral squamous cell carcinoma progression through the regulation of miR-424-5p/SCAI axis. Cancer Manag. Res.12, 7501–7514 (2020).
   PubMed Web of Science ®Google Scholar
• Tong F , MaoX, ZhangSet al. HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumour radiosensitivity. Cancer Lett.478, 34–44 (2020).
   PubMed Web of Science ®Google Scholar
• Cui J , WangH, ZhangXet al. Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B. Aging12(8), 6756–6773 (2020).
   PubMedGoogle Scholar
• Pang X , WangSS, ZhangMet al. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway. Cancer Immunol. Immunother.70(4), 1015–1029 (2021).
   PubMed Web of Science ®Google Scholar
• Yan W , WangY, ChenYet al. Exosomal miR-130b-3p promotes progression and tubular formation through targeting Pten in oral squamous cell carcinoma. Front. Cell Dev. Biol.9, 616306 (2021).
   PubMed Web of Science ®Google Scholar
• He S , ZhangW, LiXet al. Oral squamous cell carcinoma (OSCC)-derived exosomal miR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation. Bioengineered12(1), 2164–2174 (2021).
   PubMed Web of Science ®Google Scholar
• Fujiwara T , EguchiT, SogawaCet al. Carcinogenic epithelial–mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab. Oral Oncol.86, 251–257 (2018).
   PubMed Web of Science ®Google Scholar
• Kase Y , UzawaK, WagaiSet al. Engineered exosomes delivering specific tumour-suppressive RNAi attenuate oral cancer progression. Sci. Rep.11(1), 5897 (2021).
   PubMed Web of Science ®Google Scholar
• Chen G , ZhuJY, ZhangZLet al. Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery. Angew. Chem. Int. Ed. Engl.54(3), 1036–1040 (2015).
   PubMed Web of Science ®Google Scholar
• Huaitong X , YuanyongF, YueqinTet al. Microvesicles releasing by oral cancer cells enhance endothelial cell angiogenesis via Shh/RhoA signaling pathway. Cancer Biol. Ther.18(10), 783–791 (2017).
   PubMed Web of Science ®Google Scholar
• Zhu L , DongD, YuZLet al. Folate-engineered microvesicles for enhanced target and synergistic therapy toward breast cancer. ACS Appl. Mater. Interfaces9(6), 5100–5108 (2017).
   PubMed Web of Science ®Google Scholar
• Guo M , XiaC, WuYet al. Research progress on cell membrane-coated biomimetic delivery systems. Front. Bioeng. Biotechnol.9, 772522 (2021).
   PubMed Web of Science ®Google Scholar
• Luk BT , ZhangL. Cell membrane-camouflaged nanoparticles for drug delivery. J. Control. Rel.220(Pt B), 600–607 (2015).
   PubMed Web of Science ®Google Scholar
• Rodriguez PL , HaradaT, ChristianDAet al. Minimal “self” peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science339(6122), 971–975 (2013).
   PubMed Web of Science ®Google Scholar
• Feng M , JiangW, KimBYSet al. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat. Rev. Cancer19(10), 568–586 (2019).
   PubMed Web of Science ®Google Scholar
• Ye X , ZhangJ, LuR, ZhouG. Signal regulatory protein associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages. Oncotarget7(49), 81305–81321 (2016).
   PubMedGoogle Scholar
• Kang T , ZhuQ, WeiDet al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano11(2), 1397–1411 (2017).
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S , GnanasammandhanMK, XieCet al. Monocyte cell membrane-derived nanoghosts for targeted cancer therapy. Nanoscale8(13), 6981–6985 (2016).
   PubMed Web of Science ®Google Scholar
• Song K , ZhuF, ZhangHZ, ShangZJ. Tumour necrosis factor-α enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway. Exp. Cell Res.318(14), 1707–1715 (2012).
   PubMed Web of Science ®Google Scholar
• He H , GuoC, WangJet al. Leutusome: a biomimetic nanoplatform integrating plasma membrane components of leukocytes and tumour cells for remarkably enhanced solid tumour homing. Nano Lett.18(10), 6164–6174 (2018).
   PubMed Web of Science ®Google Scholar
• Castro F , MartinsC, SilveiraMJet al. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments. Adv. Drug Deliv. Rev.170, 312–339 (2021).
   PubMed Web of Science ®Google Scholar
• Chen S , ZhongY, FanWet al. Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion-drug conjugates with cell-membrane affinity. Nat. Biomed. Eng.5(9), 1019–1037 (2021).
   PubMed Web of Science ®Google Scholar
• Li Y , RazaF, LiuYet al. Clinical progress and advanced research of red blood cells based drug delivery system. Biomaterials279, 121202 (2021).
   PubMed Web of Science ®Google Scholar
• Raza F , ZafarH, ZhangSet al. Recent advances in cell membrane-derived biomimetic nanotechnology for cancer immunotherapy. Adv. Healthc. Mater.10(6), e2002081 (2021).
   PubMed Web of Science ®Google Scholar
• Zhao Y , WangJ, CaiXet al. Metal-organic frameworks with enhanced photodynamic therapy: synthesis, erythrocyte membrane camouflage, and aptamer-targeted aggregation. ACS Appl. Mater. Interfaces12(21), 23697–23706 (2020).
   PubMed Web of Science ®Google Scholar
• Chen H , DengJ, YaoXet al. Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC. J. Nanobiotechnol.19(1), 342 (2021).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• O’Donnell JS , TengMWL, SmythMJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol.16(3), 151–167 (2019).
   PubMed Web of Science ®Google Scholar
• Ye X , WangX, LuRet al. CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma. Oncol. Lett.15(6), 9075–9080 (2018).
   PubMed Web of Science ®Google Scholar
• Ye XJ , YangJG, TanYQ, ChenXJ, ZhouG. Targeting CD47 inhibits tumour development and increases phagocytosis in oral squamous cell carcinoma. Anticancer Agents Med. Chem.21(6), 766–774 (2021).
   PubMed Web of Science ®Google Scholar
• Sultan AS , XieJ, LeBaronMJet al. STAT5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene24(5), 746–760 (2005).
   PubMed Web of Science ®Google Scholar
• Rao L , BuLL, CaiBet al. Cancer cell membrane-coated upconversion nanoprobes for highly specific tumour imaging. Adv. Mater.28(18), 3460–3466 (2016).
   PubMed Web of Science ®Google Scholar
• Rao L , HeZ, MengQFet al. Effective cancer targeting and imaging using macrophage membrane-camouflaged upconversion nanoparticles. J. Biomed. Mater. Res. A105(2), 521–530 (2017).
   PubMed Web of Science ®Google Scholar
• Rao L , YuGT, MengQFet al. Cancer cell membrane-coated nanoparticles for personalized therapy in patient-derived xenograft models. Adv. Funct. Mater.29(51), 1905671 (2019).
   Web of Science ®Google Scholar
• Versteeg HH , HeemskerkJW, LeviM, ReitsmaPH. New fundamentals in hemostasis. Physiol. Rev.93(1), 327–358 (2013).
   PubMed Web of Science ®Google Scholar
• Harker LA , RoskosLK, MarzecUMet al. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood95(8), 2514–2522 (2000).
   PubMed Web of Science ®Google Scholar
• Geranpayehvaghei M , DabirmaneshB, KhalediMet al. Cancer-associated platelet-inspired nanomedicines for cancer therapy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.13(5), e1702 (2021).
   PubMed Web of Science ®Google Scholar
• Hu Q , SunW, QianCet al. Anticancer platelet-mimicking nanovehicles. Adv. Mater.27(44), 7043–7050 (2015).
   PubMed Web of Science ®Google Scholar
• Li J , AiY, WangLet al. Targeted drug delivery to circulating tumour cells via platelet membrane-functionalized particles. Biomaterials76, 52–65 (2016).
   PubMed Web of Science ®Google Scholar
• Dehaini D , WeiX, FangRHet al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv. Mater.29(16), 1606209 (2017).
   Web of Science ®Google Scholar
• Rao L , BuLL, MaLet al. Platelet-facilitated photothermal therapy of head and neck squamous cell carcinoma. Angew. Chem. Int. Ed. Engl.57(4), 986–991 (2018).
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ , DeriglasovaUF, KulaginaNNet al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol.2(2), 83–92 (1974).
   PubMed Web of Science ®Google Scholar
• Wu HH , ZhouY, TabataY, GaoJQ. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. J. Control. Rel.294, 102–113 (2019).
   PubMed Web of Science ®Google Scholar
• Bu L-L , RaoL, YuG-Tet al. Cancer stem cell-platelet hybrid membrane-coated magnetic nanoparticles for enhanced photothermal therapy of head and neck squamous cell carcinoma. Adv. Funct. Mater.29(10), 1807733 (2019).
   Web of Science ®Google Scholar
• Zhou D , ChenY, BuWet al. Modification of metal-organic framework nanoparticles using dental pulp mesenchymal stem cell membranes to target oral squamous cell carcinoma. J. Colloid. Interface Sci.601, 650–660 (2021).
   PubMed Web of Science ®Google Scholar
• Alanazi SA , AlanaziF, HaqNet al. Lipoproteins-nanocarriers as a promising approach for targeting liver cancer: present status and application prospects. Curr. Drug Deliv.17(10), 826–844 (2020).
   PubMed Web of Science ®Google Scholar
• Angsantikul P , ThamphiwatanaS, ZhangQet al. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv. Ther. (Weinh)1(2), 1800016 (2018).
   PubMedGoogle Scholar
• Chen Z , WangZ, GuZ. Bioinspired and biomimetic nanomedicines. Acc. Chem. Res.52(5), 1255–1264 (2019).
   PubMed Web of Science ®Google Scholar
• Wang Y , ZhouXM, MaXet al. Construction of nanodroplet/adiposome and artificial lipid droplets. ACS Nano10(3), 3312–3322 (2016).
   PubMed Web of Science ®Google Scholar